TLV’s recent decision on Fabhalta provides further evidence of how Sweden applies higher acceptable ICERs in very rare conditions.
Fabhalta was assessed for a very rare, severe chronic kidney disease population. Following three-party negotiations, TLV’s base case, including the confidential agreement, […]
The Swedish HTA agency TLV has announced changes to the timeline and content of its upcoming guidance on reimbursement and pricing of medicines.
Key points from the update:
📍The previously communicated timeline has been postponed. The revised guidance will enter into force […]
Choosing the right study design for the causal question
We are proud to share that a paper co-authored by Jessica Young is among the Top 10 most-cited papers in Pharmacoepidemiology and Drug Safety for 2024.
The paper, “Core Concepts in Pharmacoepidemiology: New-User Designs,” explores how […]
Den 5 maj är Anders Gustavsson vid Quantify med och arrangerar ett digitalt seminarium om hur vi i Sverige kan förbereda oss inför kommande sjukdomsmodifierande behandling vid Alzheimers sjukdom. Den primära målgruppen är kliniskt verksamma inom kognitiva sjukdomar men alla […]
Thank you for being part of our journey this past year.
2026 brings new opportunities to learn, to collaborate, and to make a difference in life science through evidence and insight.
We’re stepping into the year with optimism, curiosity, and purpose.
Wishing you […]
Thank you for 2025 – for the trust, the partnerships, and the meaningful work we’ve shared across the life science community.
From everyone at Quantify, we wish you a joyful holiday season and a restful start to the new year.
We’re recharging […]
On her way into the office, one of our colleagues captured this view: Stockholm at dawn, river reflections, lights still glowing.
A calm start to a busy week.
At Quantify Research, clarity often comes in quiet moments.
Behind every analysis is intent. Behind […]
Next week at ISPOR Europe, Quantify is proud to present three poster studies co-authored with our pharma partners; each grounded in the power of Nordic real-world data.
📍 If you’re attending, here’s where to find us:
📅 Tuesday, Nov 11
✉️ Poster 1: Mapping of […]
At today’s ISPOR Real-World Evidence Summit 2025 , Puneet Kaushik presented new insights into the economic burden of Japanese Encephalitis(JE) across Asia-Pacific.
🔍 Despite vaccines and treatments, JE continues to strain health systems through:
• High inpatient and ICU demands
• Significant productivity […]
This week, we are delighted to welcome our colleagues from Denmark and Finland to Stockholm as we kick off the fall period for the Real-World Evidence & Analytics unit. It’s a great opportunity for meetings, planning, and strengthening our overall collaboration […]